Patents by Inventor Roland F. Maes

Roland F. Maes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5183751
    Abstract: Para-amino-salicylic acid (PASA) or a water-soluble salt thereof, e.g. of an alkali metal, alkaline earth metal, ammonia or an amine is used for the stabilization of the enzymatic activity of peroxidase in aqueous medium. The stabilizing agent may be in the form of an aqueous solution compatible with peroxidase medium in which PASA or its salt is dissolved in a quantity efficacious for stabilization, preferentially comprised between about 8 .mu.g/ml and about 2000 .mu.g/ml of the solution based on PASA. With such stabilizing agent, one can efficaciously stabilize solutions of peroxidase, whether free or conjugated to immunological carrier reagents, and prepare these reagents in advance in a diluted form ready for use.
    Type: Grant
    Filed: April 30, 1991
    Date of Patent: February 2, 1993
    Inventor: Roland F. Maes
  • Patent number: 4965192
    Abstract: An interspecific antigen of Mycobacteria consists essentially of a mixture in substantially immunochemically pure form of a protein having a molecular weight of at least about 4.times.10.sup.6 Daltons and polysaccharide having a molecular weight of at least about 1.times.10.sup.6 Daltons, and has when subjected to cross-electrophoresis an immunoelectrophoretic precipitation pattern corresponding to A60-antigen of Mycobacteria bovis strain BCG. This antigen is effective for detecting the prior exposure of a subject to Mycobacterial infections by a cutaneous test.
    Type: Grant
    Filed: April 29, 1988
    Date of Patent: October 23, 1990
    Assignee: Anda Biologicals
    Inventor: Roland F. Maes
  • Patent number: 4777130
    Abstract: A 60-like antigens isolated in a one-step reaction from the bacterial cytoplasma of Mycobacteria are useful for the production of diagnostic tests.
    Type: Grant
    Filed: December 5, 1984
    Date of Patent: October 11, 1988
    Assignee: Andra Biologicals
    Inventor: Roland F. Maes
  • Patent number: 4387166
    Abstract: The sensitivity of hemagglutination inhibition tests is improved by introducing a determined amount of lyophilized antigen or antibody into serological tubes in the absence of the indicator component. The test fluid to be analyzed is incubated solely in the presence of its binding partner in a liquid phase. After completion of the binding reaction (about 5 hours but extendable to 18 hours), the sensitized indicator solid phase, usually consisting of sensitized red blood cells, is added. By this process a 10 to 20 fold increase in sensitivity of the hemagglutination inhibition test is routinely achieved.
    Type: Grant
    Filed: September 15, 1981
    Date of Patent: June 7, 1983
    Assignee: Anda Biologicals
    Inventor: Roland F. Maes